Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10557817 | 0.91 | HDAC8 (0.67) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL21389125 | 0.86 | POLB (0.66) | POLBMEN1KMT2AKDM4EMAPT | |
| SCHEMBL21480866 | 0.82 | KMT2A (0.58) | POLBMEN1KMT2AKDM4EMAPT | |
| SCHEMBL1263756 | 0.81 | ASAH1 (0.68) | MEN1KMT2AKDM4EMAPTPABPC1 | |
| SCHEMBL1262841 | 0.81 | ASAH1 (0.68) | MEN1KMT2AKDM4EMAPTPABPC1 | |
| SCHEMBL1263986 | 0.81 | ASAH1 (0.68) | MEN1KMT2AKDM4EMAPTPABPC1 | |
| SCHEMBL1263084 | 0.81 | ASAH1 (0.68) | MEN1KMT2AKDM4EMAPTPABPC1 | |
| SCHEMBL1263334 | 0.81 | ASAH1 (0.68) | MEN1KMT2AKDM4EMAPTPABPC1 | |
| SCHEMBL1262992 | 0.81 | ASAH1 (0.68) | MEN1KMT2AKDM4EMAPTPABPC1 | |
| SCHEMBL1263338 | 0.81 | ASAH1 (0.68) | MEN1KMT2AKDM4EMAPTPABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200055808-A1 | COMPOSITION FOR USE IN DETECTING AN ALLERGY TO CLAVULANIC ACID | UNIVERSIDAD DE MÁLAGA (ES) | 2020-02-20 | — | — | US | disclosed |
| EP-3505508-A2 | COMPOSITION FOR USE IN DETECTING AN ALLERGY TO CLAVULANIC ACID | Servicio Andaluz De Salud (ES) | 2019-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200055808-A1 | COMPOSITION FOR USE IN DETECTING AN ALLERGY TO CLAVULANIC ACID | CMA1, KIT, IL5 | POLB 1767/4885MEN1 1743/4885KMT2A 3599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.